Order Article Reprints

D’Onofrio V, Porrez S, Jacobs B, Alhatemi A, De Boever F, Waerlop G, Michels E, Vanni F, Manenti A, Leroux-Roels G, et al. Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study. Vaccines. 2024; 12(9):1036. https://doi.org/10.3390/vaccines12091036

D’Onofrio, Valentino, Sharon Porrez, Bart Jacobs, Azhar Alhatemi, Fien De Boever, Gwenn Waerlop, Els Michels, Francesca Vanni, Alessandro Manenti, Geert Leroux-Roels, and et al. 2024. "Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study" Vaccines 12, no. 9: 1036. https://doi.org/10.3390/vaccines12091036

D’Onofrio, V., Porrez, S., Jacobs, B., Alhatemi, A., De Boever, F., Waerlop, G., Michels, E., Vanni, F., Manenti, A., Leroux-Roels, G., Platenburg, P. P., Hilgers, L., & Leroux-Roels, I. (2024). Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study. Vaccines, 12(9), 1036. https://doi.org/10.3390/vaccines12091036